Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407179

Medchemexpress LLC Sodium butyrate | 156-54-7 | 99.8% | 500 MG
SDP

Catalog No. 5000407179
Encompass_Preferred

Sodium Butyrate is an inhibitor of HDAC, exhibiting anti-tumor activity. It induces morphological changes, inhibits cell proliferation, and impairs cell viability in nasopharyngeal carcinoma (NPC) cells. It is for research use only.

  • Inhibits HDAC activity.
  • Possesses anti-tumor activity.
  • Induces morphological changes and inhibits proliferation in NPC cells.
  • Cytotoxic to NPC cells (5-8F and 6-10B cell lines).
  • Promotes apoptosis in nasopharyngeal carcinoma cells.
  • Reduces cell viability and key protein levels (p-mTOR, PCNA).
  • Induces cell cycle arrest in the G0/G1 phase.

Catalog No. 50-004-07179 Supplier Medchemexpress LLC Supplier No. HYB0350A500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Sodium Butyrate is an inhibitor of HDAC, exhibiting anti-tumor activity. It induces morphological changes, inhibits cell proliferation, and impairs cell viability in nasopharyngeal carcinoma (NPC) cells. It is for research use only.

  • Inhibits HDAC activity.
  • Possesses anti-tumor activity.
  • Induces morphological changes and inhibits proliferation in NPC cells.
  • Cytotoxic to NPC cells (5-8F and 6-10B cell lines).
  • Promotes apoptosis in nasopharyngeal carcinoma cells.
  • Reduces cell viability and key protein levels (p-mTOR, PCNA).
  • Induces cell cycle arrest in the G0/G1 phase.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.